|
1
|
Wolf P: The nature and significance of
platelet products in human plasma. Br J Haematol. 13:269–288. 1967.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pan BT and Johnstone RM: Fate of the
transferrin receptor during maturation of sheep reticulocytes in
vitro: Selective externalization of the receptor. Cell. 33:967–978.
1983. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Johnstone RM, Adam M, Hammond JR, Orr L
and Turbide C: Vesicle formation during reticulocyte maturation.
Association of plasma membrane activities with released vesicles
(exosomes). J Biol Chem. 262:9412–9420. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bonifacino JS: Vesicular transport earns a
nobel. Trends Cell Biol. 24:3–5. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jadli AS, Ballasy N, Edalat P and Patel
VB: Inside(sight) of tiny communicator: Exosome biogenesis,
secretion, and uptake. Mol Cell Biochem. 467:77–94. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ruivo CF, Adem B, Silva M and Melo SA: The
biology of cancer exosomes: Insights and new perspectives. Cancer
Res. 77:6480–6488. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kok VC and Yu CC: Cancer-derived exosomes:
Their role in cancer biology and biomarker development. Int J
Nanomedicine. 15:8019–8036. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Plebanek MP, Angeloni NL, Vinokour E, Li
J, Henkin A, Martinez-Marin D, Filleur S, Bhowmick R, Henkin J,
Miller SD, et al: Pre-metastatic cancer exosomes induce immune
surveillance by patrolling monocytes at the metastatic niche. Nat
Commun. 8:13192017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim MS, Haney MJ, Zhao Y, Mahajan V,
Deygen I, Klyachko NL, Inskoe E, Piroyan A, Sokolsky M, Okolie O,
et al: Development of exosome-encapsulated paclitaxel to overcome
MDR in cancer cells. Nanomedicine. 12:655–664. 2016. View Article : Google Scholar :
|
|
10
|
Möller A and Lobb RJ: The evolving
translational potential of small extracellular vesicles in cancer.
Nat Rev Cancer. 20:697–709. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kalluri R and LeBleu VS: The biology,
function, and biomedical applications of exosomes. Science.
367:eaau69772020. View Article : Google Scholar :
|
|
12
|
Simons M and Raposo G: Exosomes-vesicular
carriers for intercellular communication. Curr Opin Cell Biol.
21:575–581. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fujita Y, Kosaka N, Araya J, Kuwano K and
Ochiya T: Extracellular vesicles in lung microenvironment and
pathogenesis. Trends Mol Med. 21:533–542. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hoshino D, Kirkbride KC, Costello K, Clark
ES, Sinha S, Grega-Larson N, Tyska MJ and Weaver AM: Exosome
secretion is enhanced by invadopodia and drives invasive behavior.
Cell Rep. 5:1159–1168. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Colombo M, Raposo G and Thery C:
Biogenesis, secretion, and intercellular interactions of exosomes
and other extracellular vesicles. Annu Rev Cell Dev Biol.
30:255–289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Frydrychowicz M, Koleckabednarczyk A,
Madejczyk M, Yasar S and Dworacki G: Exosomes-structure, biogenesis
and biological role in non-small-cell lung cancer. Scand J Immunol.
81:2–10. 2015. View Article : Google Scholar
|
|
17
|
Frühbeis C, Fröhlich D, Kuo WP, Amphornrat
J, Thilemann S, Saab AS, Kirchhoff F, Möbius W, Goebbels S, Nave
KA, et al: Neurotransmitter-triggered transfer of exosomes mediates
oligodendrocyte-neuron communication. PLoS Biol. 11:e10016042013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zylbersztejn K and Galli T: Vesicular
traffic in cell navigation. FEBS J. 278:4497–4505. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tran N: Cancer exosomes as miRNA
factories. Trends Cancer. 2:329–331. 2016. View Article : Google Scholar
|
|
20
|
Melo SA, Sugimoto H, O'Connell JT, Kato N,
Villanueva A, Vidal A, Qiu L, Vitkin E, Perelman LT, Melo CA, et
al: Cancer exosomes perform cell-independent microRNA biogenesis
and promote tumorigenesis. Cancer Cell. 26:707–721. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang J, Yeung BZ, Cui M, Peer CJ, Lu Z,
Figg WD, Guillaume Wientjes M, Woo S and Au JL: Exosome is a
mechanism of intercellular drug transfer: Application of
quantitative pharmacology. J Control Release. 268:147–158. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wei Y, Wang D, Jin F, Bian Z, Li L, Liang
H, Li M, Shi L, Pan C, Zhu D, et al: Pyruvate kinase type M2
promotes tumour cell exosome release via phosphorylating
synaptosome-associated protein 23. Nat Commun. 8:140412017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gu H, Chen C, Hao X, Wang C, Zhang X, Li
Z, Shao H, Zeng H, Yu Z, Xie L, et al: Sorting protein VPS33B
regulates exosomal autocrine signaling to mediate hematopoiesis and
leukemogenesis. J Clin Invest. 126:4537–4553. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fan Q, Yang L, Zhang X, Peng X, Wei S, Su
D, Zhai Z, Hua X and Li H: The emerging role of exosome-derived
non-coding RNAs in cancer biology. Cancer Lett. 414:107–115. 2018.
View Article : Google Scholar
|
|
25
|
Bobrie A, Colombo M, Raposo G and Théry C:
Exosome secretion: Molecular mechanisms and roles in immune
responses. Traffic. 12:1659–1668. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li I and Nabet BY: Exosomes in the tumor
microenvironment as mediators of cancer therapy resistance. Mol
Cancer. 18:322019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wortzel I, Dror S, Kenific CM and Lyden D:
Exosome-mediated metastasis: Communication from a distance. Dev
Cell. 49:347–360. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sung BH, Ketova T, Hoshino D, Zijlstra A
and Weaver AM: Directional cell movement through tissues is
controlled by exosome secretion. Nat Commun. 6:71642015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hoshino A, Costa-Silva B, Shen TL,
Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di
Giannatale A, Ceder S, et al: Tumour exosome integrins determine
organotropic metastasis. Nature. 527:329–335. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Milane L, Singh A, Mattheolabakis G,
Suresh M and Amiji MM: Exosome mediated communication within the
tumor microenvironment. J Control Release. 219:278–294. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Junttila MR and de Sauvage FJ: Influence
of tumour micro-environment heterogeneity on therapeutic response.
Nature. 501:346–354. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tsukamoto H, Fujieda K, Senju S, Ikeda T,
Oshiumi H and Nishimura Y: Immune-suppressive effects of
interleukin-6 on T-cell-mediated anti-tumor immunity. Cancer Sci.
109:523–530. 2018. View Article : Google Scholar
|
|
33
|
Nishikawa H and Sakaguchi S: Regulatory T
cells in cancer immunotherapy. Curr Opin Immunol. 27:1–7. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Warburg O, Wind F and Negelein E: The
metabolism of tumors in the body. J Gen Physiol. 8:519–530. 1927.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gatenby RA, Gawlinski ET, Gmitro AF,
Kaylor BM and Gillies RJ: Acid-mediated tumor invasion: A
multidisciplinary study. Cancer Res. 66:5216–5223. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pace KR, Dutt R and Galileo DS: Exosomal
L1CAM stimulates glioblastoma cell motility, proliferation, and
invasiveness. Int J Mol Sci. 20:39822019. View Article : Google Scholar :
|
|
37
|
Guo L, Zhu Y, Li L, Zhou S, Yin G, Yu G
and Cui H: Breast cancer cell-derived exosomal miR-20a-5p promotes
the proliferation and differentiation of osteoclasts by targeting
SRCIN1. Cancer Med. 8:5687–5701. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang S, Su X, Xu M, Xiao X, Li X, Li H,
Keating A and Zhao RC: Exosomes secreted by mesenchymal
stromal/stem cell-derived adipocytes promote breast cancer cell
growth via activation of Hippo signaling pathway. Stem Cell Res
Ther. 10:1172019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lee FT, Mountain AJ, Kelly MP, Hall C,
Rigopoulos A, Johns TG, Smyth FE, Brechbiel MW, Nice EC, Burgess AW
and Scott AM: Enhanced efficacy of radioimmunotherapy with
90Y-CHX-A′-DTPA-hu3S193 by inhibition of epidermal growth factor
receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor
AG1478. Clin Cancer Res. 11:7080s–7086s. 2005. View Article : Google Scholar
|
|
40
|
Luo F, Sun Z, Han Q, Xue C and Bai C:
Effect of human hepatocellular carcinoma HepG2 Cell-derived exosome
on the differentiation of mesenchymal stem cells and their
interaction. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 39:312–317.
2017.PubMed/NCBI
|
|
41
|
Amit M, Takahashi H, Dragomir MP,
Lindemann A, Gleber-Netto FO, Pickering CR, Anfossi S, Osman AA,
Cai Y, Wang R, et al: Loss of p53 drives neuron reprogramming in
head and neck cancer. Nature. 578:449–454. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Godlewski J, Ferrerluna R, Rooj AK, Mineo
M, Ricklefs F, Takeda YS, Nowicki MO, Salińska E, Nakano I, Lee H,
et al: MicroRNA signatures and molecular subtypes of glioblastoma:
The role of extracellular transfer. Stem Cell Reports. 8:1497–1505.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Qu L, Ding J, Chen C, Wu ZJ, Liu B, Gao Y,
Chen W, Liu F, Sun W, Li XF, et al: Exosome-transmitted lncARSR
promotes sunitinib resistance in renal cancer by acting as a
competing endogenous RNA. Cancer Cell. 29:653–668. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lunavat TR, Cheng L, Einarsdottir BO,
Olofsson Bagge R, Veppil Muralidharan S, Sharples RA, Lässer C, Gho
YS, Hill AF, Nilsson JA and Lötvall J: BRAFV600
inhibition alters the microRNA cargo in the vesicular secretome of
malignant melanoma cells. Proc Natl Acad Sci SA. 114:E5930–E5939.
2017. View Article : Google Scholar
|
|
45
|
Mikamori M, Yamada D, Eguchi H, Hasegawa
S, Kishimoto T, Tomimaru Y, Asaoka T, Noda T, Wada H, Kawamoto K,
et al: MicroRNA-155 controls exosome synthesis and promotes
gemcitabine resistance in pancreatic ductal adenocarcinoma. Sci
Rep. 7:423392017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lobb RJ, Van Amerongen R, Wiegmans AP, Ham
S, Larsen JE and Möller A: Exosomes derived from mesenchymal
non-small cell lung cancer cells promote chemoresistance. Int J
Cancer. 141:614–620. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bach D, Hong J, Park HJ and Lee SK: The
role of exosomes and miRNAs in drug-resistance of cancer cells. Int
J Cancer. 141:220–230. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Crompot E, Van Damme M, Pieters K,
Vermeersch M, Perez-Morga D, Mineur P, Maerevoet M, Meuleman N,
Bron D, Lagneaux L and Stamatopoulos B: Extracellular vesicles of
bone marrow stromal cells rescue chronic lymphocytic leukemia B
cells from apoptosis, enhance their migration and induce gene
expression modifications. Haematologica. 102:1594–1604. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hu JL, Wang W, Lan X, Zeng ZC, Liang YS,
Yan YR, Song FY, Wang FF, Zhu XH, Liao WJ, et al: CAFs secreted
exosomes promote metastasis and chemotherapy resistance by
enhancing cell stemness and epithelial-mesenchymal transition in
colorectal cancer. Mol Cancer. 18:912019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Richards KE, Zeleniak AE, Fishel ML, Wu J,
Littlepage LE and Hill R: Cancer-associated fibroblast exosomes
regulate survival and proliferation of pancreatic cancer cells.
Oncogene. 36:1770–1778. 2017. View Article : Google Scholar :
|
|
51
|
Wu H, Zeng C, Ye Y, Liu J, Mu Z, Xie Y,
Chen B, Nong Q and Wu D: Exosomes from irradiated nonsmall cell
lung cancer cells reduced sensitivity of recipient cells to
anaplastic lymphoma kinase inhibitors. Mol Pharm. 15:1892–1900.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Feng Q, Zhang C, Lum D, Druso JE, Blank B,
Wilson KF, Welm A, Antonyak MA and Cerione RA: A class of
extracellular vesicles from breast cancer cells activates VEGF
receptors and tumour angiogenesis. Nat Commun. 8:144502017.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Lazar I, Clement E, Dauvillier S, Milhas
D, Ducoux-Petit M, LeGonidec S, Moro C, Soldan V, Dalle S, Balor S,
et al: Adipocyte exosomes promote melanoma aggressiveness through
fatty acid oxidation: A novel mechanism linking obesity and cancer.
Cancer Res. 76:4051–4057. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Fang T, Lv H, Lv G, Li T, Wang C, Han Q,
Yu L, Su B, Guo L, Huang S, et al: Tumor-derived exosomal
miR-1247-3p induces cancer-associated fibroblast activation to
foster lung metastasis of liver cancer. Nat Commun. 9:1912018.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yan W, Wu X, Zhou W, Fong MY, Cao M, Liu
J, Liu X, Chen CH, Fadare O, Pizzo DP, et al: Cancer-cell-secreted
exosomal miR-105 promotes tumour growth through the MYC-dependent
metabolic reprogramming of stromal cells. Nat Cell Biol.
20:597–609. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
McAtee CO, Booth C, Elowsky C, Zhao L,
Payne J, Fangman T, Caplan S, Henry MD and Simpson MA: Prostate
tumor cell exosomes containing hyaluronidase Hyal1 stimulate
prostate stromal cell motility by engagement of FAK-mediated
integrin signaling. Matrix Biol. 78-79:165–179. 2019. View Article : Google Scholar
|
|
57
|
Becker A, Thakur BK, Weiss JM, Kim HS,
Peinado H and Lyden D: Extracellular vesicles in cancer:
Cell-to-cell mediators of metastasis. Cancer Cell. 30:836–848.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Todorova D, Simoncini S, Lacroix R,
Sabatier F and Dignat-George F: Extracellular vesicles in
angiogenesis. Circ Res. 120:1658–1673. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Bao L, You B, Shi S, Shan Y, Zhang Q, Yue
H, Zhang J, Zhang W, Shi Y, Liu Y, et al: Metastasis-associated
miR-23a from nasopharyngeal carcinoma-derived exosomes mediates
angiogenesis by repressing a novel target gene TSGA10. Oncogene.
37:2873–2889. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Chen Y, Zeng C, Zhan Y, Wang H, Jiang X
and Li W: Aberrant low expression of p85α in stromal fibroblasts
promotes breast cancer cell metastasis through exosome-mediated
paracrine Wnt10b. Oncogene. 36:4692–4705. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zhang G, Zhang W, Li B, Stringer-Reasor E,
Chu C, Sun L, Bae S, Chen D, Wei S, Jiao K, et al: MicroRNA-200c
and microRNA-141 are regulated by a FOXP3-KAT2B axis and associated
with tumor metastasis in breast cancer. Breast Cancer Res.
19:732017. View Article : Google Scholar
|
|
62
|
Hsu YL, Hung J, Chang W, Lin YS, Pan YC,
Tsai PH, Wu CY and Kuo PL: Hypoxic lung cancer-secreted exosomal
miR-23a increased angiogenesis and vascular permeability by
targeting prolyl hydroxylase and tight junction protein ZO-1.
Oncogene. 36:4929–4942. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Xia X, Wang S, Ni B, Xing S, Cao H, Zhang
Z, Yu F, Zhao E and Zhao G: Hypoxic gastric cancer-derived exosomes
promote progression and metastasis via MiR-301a-3p/PHD3/HIF-1α
positive feedback loop. Oncogene. 39:6231–6244. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Fang JH, Zhang ZJ, Shang LR, Luo YW, Lin
YF, Yuan Y and Zhuang SM: Hepatoma cell-secreted exosomal
microRNA-103 increases vascular permeability and promotes
metastasis by targeting junction proteins. Hepatology.
68:1459–1475. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Matei I, Kim HS and Lyden D: Unshielding
exosomal RNA unleashes tumor growth and metastasis. Cell.
170:223–225. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Yamamura Y, Asai N, Enomoto A, Kato T, Mii
S, Kondo Y, Ushida K, Niimi K, Tsunoda N, Nagino M, et al:
Akt-Girdin signaling in cancer-associated fibroblasts contributes
to tumor progression. Cancer Res. 75:813–823. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Kong J, Tian H, Zhang F, Zhang Z, Li J,
Liu X, Li X, Liu J, Li X, Jin D, et al: Extracellular vesicles of
carcinoma-associated fibroblasts creates a pre-metastatic niche in
the lung through activating fibroblasts. Mol Cancer. 18:1752019.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Zhang H, Deng T, Liu R, Bai M, Zhou L,
Wang X, Li S, Wang X, Yang H, Li J, et al: Exosome-delivered EGFR
regulates liver microenvironment to promote gastric cancer liver
metastasis. Nat Commun. 8:150162017. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Liu Y, Gu Y, Han Y, Zhang Q, Jiang Z,
Zhang X, Huang B, Xu X, Zheng J and Cao X: Tumor exosomal RNAs
promote lung pre-metastatic niche formation by activating alveolar
epithelial TLR3 to recruit neutrophils. Cancer Cell. 30:243–256.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Lane AN, Higashi RM and Fan TW: Metabolic
reprogramming in tumors: Contributions of the tumor
microenvironment. Genes Dis. 7:185–198. 2019. View Article : Google Scholar
|
|
71
|
Ji K, Mayernik L, Moin K and Sloane BF:
Acidosis and proteolysis in the tumor microenvironment. Cancer
Metastasis Rev. 38:103–112. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Zhao H, Yang L, Baddour J, Achreja A,
Bernard V, Moss T, Marini JC, Tudawe T, Seviour EG, San Lucas FA,
et al: Tumor microenvironment derived exosomes pleiotropically
modulate cancer cell metabolism. Elife. 5:e102502016. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Li Y, Zhao Z, Liu W and Li X: SNHG3
functions as miRNA sponge to promote breast cancer cells growth
through the metabolic reprogramming. Appl Biochem Biotechnol.
191:1084–1099. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Tomasetti M, Lee W, Santarelli L and
Neuzil J: Exosome-derived microRNAs in cancer metabolism: Possible
implications in cancer diagnostics and therapy. Exp Mol Med.
49:e2852017. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Greening DW, Gopal SK, Xu R, Simpson RJ
and Chen W: Exosomes and their roles in immune regulation and
cancer. Semin Cell Dev Biol. 40:72–81. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Filipazzi P, Bürdek M, Villa A, Rivoltini
L and Huber V: Recent advances on the role of tumor exosomes in
immunosuppression and disease progression. Semin Cancer Biol.
22:342–349. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Wolfers J, Lozier A, Raposo G, Regnault A,
Théry C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, et
al: Tumor-derived exosomes are a source of shared tumor rejection
antigens for CTL cross-priming. Nat Med. 7:297–303. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Dai S, Zhou X, Wang B, Wang Q, Fu Y, Chen
T, Wan T, Yu Y and Cao X: Enhanced induction of dendritic cell
maturation and HLA-A*0201-restricted CEA-specific CD8(+) CTL
response by exosomes derived from IL-18 gene-modified CEA-positive
tumor cells. J Mol Med (Berl). 84:1067–1076. 2006. View Article : Google Scholar
|
|
79
|
Altieri SL, Khan AN and Tomasi TB:
Exosomes from plasmacytoma cells as a tumor vaccine. J Immunother.
27:282–288. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Balan S and Bhardwaj N: Cross-presentation
of tumor antigens is ruled by synaptic transfer of vesicles among
dendritic cell subsets. Cancer Cell. 37:751–753. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Zitvogel L, Regnault A, Lozier A, Wolfers
J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G and
Amigorena S: Eradication of established murine tumors using a novel
cell-free vaccine: Dendritic cell-derived exosomes. Nat Med.
4:594–600. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Pitt JM, André F, Amigorena S, Soria JC,
Eggermont A, Kroemer G and Zitvogel L: Dendritic cell-derived
exosomes for cancer therapy. J Clin Invest. 126:1224–1232. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Kitai Y, Kawasaki T, Sueyoshi T, Kobiyama
K, Ishii KJ, Zou J, Akira S, Matsuda T and Kawai T: DNA-containing
exosomes derived from cancer cells treated with topotecan activate
a STING-dependent pathway and reinforce antitumor immunity. J
Immunol. 198:1649–1659. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Dai S, Wan T, Wang B, Zhou X, Xiu F, Chen
T, Wu Y and Cao X: More efficient induction of
HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific
CTL response by immunization with exosomes prepared from
heat-stressed CEA-positive tumor cells. Clin Cancer Res.
11:7554–7563. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Czernek L and Düchler M: Functions of
cancer-derived extracellular vesicles in immunosuppression. Arch
Immunol Ther Exp (Warsz). 65:311–323. 2017. View Article : Google Scholar
|
|
86
|
Ludwig S, Floros T, Theodoraki MN, Hong
CS, Jackson EK, Lang S and Whiteside TL: Suppression of lymphocyte
functions by plasma exosomes correlates with disease activity in
patients with head and neck cancer. Clin Cancer Res. 23:4843–4854.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Wang X, Shen H, Zhangyuan G, Huang R,
Zhang W, He Q, Jin K, Zhuo H, Zhang Z, Wang J, et al: 14-3-3ζ
delivered by hepatocellular carcinoma-derived exosomes impaired
anti-tumor function of tumor-infiltrating T lymphocytes. Cell Death
Dis. 9:1592018. View Article : Google Scholar
|
|
88
|
Wen SW, Sceneay J, Lima LG, Wong CS,
Becker M, Krumeich S, Lobb RJ, Castillo V, Wong KN, Ellis S, et al:
The biodistribution and immune suppressive effects of breast
cancer-derived exosomes. Cancer Res. 76:6816–6827. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Poggio M, Hu T, Pai CC, Chu B, Belair CD,
Chang A, Montabana E, Lang UE, Fu Q, Fong L and Blelloch R:
Suppression of exosomal PD-L1 induces systemic anti-tumor immunity
and memory. Cell. 177:414–427.e13. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Gabrusiewicz K, Li X, Wei J, Hashimoto Y,
Marisetty AL, Ott M, Wang F, Hawke D, Yu J, Healy LM, et al:
Glioblastoma stem cell-derived exosomes induce M2 macrophages and
PD-L1 expression on human monocytes. Oncoimmunology.
7:e14129092018. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Razzo BM, Ludwig N, Hong CS, Sharma P,
Fabian KP, Fecek RJ, Storkus WJ and Whiteside TL: Tumor-derived
exosomes promote carcinogenesis of murine oral squamous cell
carcinoma. Carcinogenesis. 41:625–633. 2020. View Article : Google Scholar
|
|
92
|
Haderk F, Schulz R, Iskar M, Cid LL, Worst
T, Willmund KV, Schulz A, Warnken U, Seiler J, Benner A, et al:
Tumor-derived exosomes modulate PD-L1 expression in monocytes. Sci
Immunol. 2:eaah55092017. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Chen X, Zhou J, Li X and Wang X, Lin Y and
Wang X: Exosomes derived from hypoxic epithelial ovarian cancer
cells deliver microRNAs to macrophages and elicit a tumor-promoted
phenotype. Cancer Lett. 435:80–91. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Wang X, Luo G, Zhang K, Cao J, Huang C,
Jiang T, Liu B, Su L and Qiu Z: Hypoxic tumor-derived exosomal
miR-301a mediates M2 macrophage polarization via PTEN/PI3Kγ to
promote pancreatic cancer metastasis. Cancer Res. 78:4586–4598.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Hsieh CH, Tai SK and Yang MH:
Snail-overexpressing cancer cells promote M2-like polarization of
tumor-associated macrophages by delivering MiR-21-abundant
exosomes. Neoplasia. 20:775–788. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Cooks T, Pateras IS, Jenkins LM, Patel KM,
Robles AI, Morris J, Forshew T, Appella E, Gorgoulis VG and Harris
CC: Mutant p53 cancers reprogram macrophages to tumor supporting
macrophages via exosomal miR-1246. Nat Commun. 9:7712018.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Casadei L, Calore F, Creighton CJ,
Guescini M, Batte K, Iwenofu OH, Zewdu A, Braggio DA, Bill KL,
Fadda P, et al: Exosome-derived miR-25-3p and miR-92a-3p stimulate
liposarcoma progression. Cancer Res. 77:3846–3856. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Whiteside TL: Tumor-derived exosomes and
their role in cancer progression. Adv Clin Chem. 74:103–141. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Szabo G and Momen-Heravi F: Extracellular
vesicles in liver disease and potential as biomarkers and
therapeutic targets. Nat Rev Gastroenterol Hepatol. 14:455–466.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Jin X, Chen Y, Chen H, Fei S, Chen D, Cai
X, Liu L, Lin B, Su H, Zhao L, et al: Evaluation of tumor-derived
exosomal miRNA as potential diagnostic biomarkers for early-stage
non-small cell lung cancer using next-generation sequencing. Clin
Cancer Res. 23:5311–5319. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Xue M, Chen W, Xiang A, Wang R, Chen H,
Pan J, Pang H, An H, Wang X, Hou H and Li X: Hypoxic exosomes
facilitate bladder tumor growth and development through
transferring long non-coding RNA-UCA1. Mol Cancer. 16:1432017.
View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Logozzi M, Angelini DF, Iessi E, Mizzoni
D, Di Raimo R, Federici C, Lugini L, Borsellino G, Gentilucci A,
Pierella F, et al: Increased PSA expression on prostate cancer
exosomes in in vitro condition and in cancer patients. Cancer Lett.
403:318–329. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Puhka M, Takatalo M, Nordberg ME, Valkonen
S, Nandania J, Aatonen M, Yliperttula M, Laitinen S, Velagapudi V,
Mirtti T, et al: Metabolomic profiling of extracellular vesicles
and alternative normalization methods reveal enriched metabolites
and strategies to study prostate cancer-related changes.
Theranostics. 7:3824–3841. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Johnson SM, Dempsey C, Chadwick AL,
Harrison S, Liu J, Di Y, McGinn OJ, Fiorillo M, Sotgia F, Lisanti
MP, et al: Metabolic reprogramming of bone marrow stromal cells by
leukemic extracellular vesicles in acute lymphoblastic leukemia.
Blood. 128:453–456. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Yu X, Harris SL and Levine AJ: The
regulation of exosome secretion: A novel function of the p53
protein. Cancer Res. 66:4795–4801. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Wu F, Yin Z, Yang L, Fan J, Xu J, Jin Y,
Yu J, Zhang D and Yang G: Smoking induced extracellular vesicles
release and their distinct properties in non-small cell lung
cancer. J Cancer. 10:3435–3443. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Zhou W, Woodson M, Sherman MB, Neelakanta
G and Sultana H: Exosomes mediate Zika virus transmission through
SMPD3 neutral sphingomyelinase in cortical neurons. Emerg Microbes
Infect. 8:307–326. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Baumann K: Making more exosomes. Nat Rev
Mol Cell Biol. 22:2422021. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Adams SD, Csere J, D'Angelo G, Carter EP,
Romao M, Arnandis T, Dodel M, Kocher HM, Grose R, Raposo G, et al:
Centrosome amplification mediates small extracellular vesicle
secretion via lysosome disruption. Curr Biol. 31:1403–1416.e7.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Lin Y, Dong H, Deng W, Lin W, Li K, Xiong
X, Guo Y, Zhou F, Ma C, Chen Y, et al: Evaluation of salivary
exosomal chimeric GOLM1-NAA35 RNA as a potential biomarker in
esophageal carcinoma. Clin Cancer Res. 25:3035–3045. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Hu Y, Qi C, Liu X, Zhang C, Gao J, Wu Y,
Yang J, Zhao Q, Li J, Wang X and Shen L: Malignant ascites-derived
exosomes promote peritoneal tumor cell dissemination and reveal a
distinct miRNA signature in advanced gastric cancer. Cancer Lett.
457:142–150. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Manier S, Liu CJ, Avet-Loiseau H, Park J,
Shi J, Campigotto F, Salem KZ, Huynh D, Glavey SV, Rivotto B, et
al: Prognostic role of circulating exosomal miRNAs in multiple
myeloma. Blood. 129:2429–2436. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Ye SB, Zhang H, Cai TT, Liu YN, Ni JJ, He
J, Peng JY, Chen QY, Mo HY, Jun Cui, et al: Exosomal miR-24-3p
impedes T-cell function by targeting FGF11 and serves as a
potential prognostic biomarker for nasopharyngeal carcinoma. J
Pathol. 240:329–340. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
He L, Ping F, Fan Z, Zhang C, Deng M,
Cheng B and Xia J: Salivary exosomal miR-24-3p serves as a
potential detective biomarker for oral squamous cell carcinoma
screening. Biomed Pharmacother. 121:1095532020. View Article : Google Scholar
|
|
115
|
Zou X, Zhu D, Zhang H, Zhang S, Zhou X, He
X, Zhu J and Zhu W: MicroRNA expression profiling analysis in serum
for nasopharyngeal carcinoma diagnosis. Gene. 727:1442432020.
View Article : Google Scholar
|
|
116
|
Xu JF, Wang YP, Zhang SJ, Chen Y, Gu HF,
Dou XF, Xia B, Bi Q and Fan SW: Exosomes containing differential
expression of microRNA and mRNA in osteosarcoma that can predict
response to chemotherapy. Oncotarget. 8:75968–75978. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Wang J, Li W, Zhang L, Ban L, Chen P, Du
W, Feng X and Liu BF: Chemically edited exosomes with dual ligand
purified by microfluidic device for active targeted drug delivery
to tumor cells. ACS Appl Mater Interfaces. 9:27441–27452. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
He C, Zheng S, Luo Y and Wang B: Exosome
theranostics: Biology and translational medicine. Theranostics.
8:237–255. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Charoenviriyakul C, Takahashi Y, Morishita
M, Matsumoto A, Nishikawa M and Takakura Y: Cell type-specific and
common characteristics of exosomes derived from mouse cell lines:
Yield, physicochemical properties, and pharmacokinetics. Eur J
Pharm Sci. 96:316–322. 2017. View Article : Google Scholar
|
|
120
|
Kamerkar S, LeBleu VS, Sugimoto H, Yang S,
Ruivo CF, Melo SA, Lee JJ and Kalluri R: Exosomes facilitate
therapeutic targeting of oncogenic KRAS in pancreatic cancer.
Nature. 546:498–503. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Pi F, Binzel DW, Lee TJ, Li Z, Sun M,
Rychahou P, Li H, Haque F, Wang S, Croce CM, et al: Nanoparticle
orientation to control RNA loading and ligand display on
extracellular vesicles for cancer regression. Nat Nanotechnol.
13:82–89. 2018. View Article : Google Scholar :
|
|
122
|
Bellavia D, Raimondo S, Calabrese G, Forte
S, Cristaldi M, Patinella A, Memeo L, Manno M, Raccosta S, Diana P,
et al: Interleukin 3-receptor targeted exosomes inhibit in vitro
and in vivo chronic myelogenous leukemia cell growth. Theranostics.
7:1333–1345. 2017. View Article : Google Scholar :
|
|
123
|
Bliss SA, Sinha G, Sandiford OA, Williams
LM, Engelberth DJ, Guiro K, Isenalumhe LL, Greco SJ, Ayer S, Bryan
M, et al: Mesenchymal stem cell-derived exosomes stimulate cycling
quiescence and early breast cancer dormancy in bone marrow. Cancer
Res. 76:5832–5844. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Kim SM, Yang Y, Oh SJ, Hong Y, Seo M and
Jang M: Cancer-derived exosomes as a delivery platform of
CRISPR/Cas9 confer cancer cell tropism-dependent targeting. J
Control Release. 266:8–16. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Agrawal AK, Aqil F, Jeyabalan J, Spencer
WA, Beck J, Gachuki BW, Alhakeem SS, Oben K, Munagala R, Bondada S
and Gupta RC: Milk-derived exosomes for oral delivery of
paclitaxel. Nanomedicine. 13:1627–1636. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Cheng L, Wang Y and Huang L: Exosomes from
M1-Polarized macrophages potentiate the cancer vaccine by creating
a pro-inflammatory microenvironment in the lymph node. Mol Ther.
25:1665–1675. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Rao Q, Zuo B, Lu Z, Gao X, You A, Wu C, Du
Z and Yin H: Tumor-derived exosomes elicit tumor suppression in
murine hepatocellular carcinoma models and humans in vitro.
Hepatology. 64:456–472. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Zuo B, Qi H, Lu Z, Chen L, Sun B, Yang R,
Zhang Y, Liu Z, Gao X, You A, et al: Alarmin-painted exosomes
elicit persistent antitumor immunity in large established tumors in
mice. Nat Commun. 11:17902020. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Lu Z, Zuo B, Jing R, Gao X, Rao Q, Liu Z,
Qi H, Guo H and Yin H: Dendritic cell-derived exosomes elicit tumor
regression in autochthonous hepatocellular carcinoma mouse models.
J Hepatol. 67:739–748. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Morishita M, Takahashi Y, Matsumoto A,
Nishikawa M and Takakura Y: Exosome-based tumor antigens-adjuvant
co-delivery utilizing genetically engineered tumor cell-derived
exosomes with immunostimulatory CpG DNA. Biomaterials. 111:55–65.
2016. View Article : Google Scholar : PubMed/NCBI
|
